Long-term results of the high-risk patient cohort (cohort A) in the PARTNER
trial, released at the American College of Cardiology Scientific Sessions in San Francisco this March, showed that three-year outcomes of transcatheter heart valve replacement with Edwards Lifesciences Corp.’s...